These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 25995284)

  • 21. Non-invasive test for Down's syndrome.
    Pract Midwife; 2015 May; 18(5):10. PubMed ID: 26336776
    [No Abstract]   [Full Text] [Related]  

  • 22. First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction.
    Bellver J; Lara C; Soares SR; Ramírez A; Pellicer A; Remohí J; Serra V
    Hum Reprod; 2005 Sep; 20(9):2623-7. PubMed ID: 15905286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antenatal screening for Down's syndrome.
    Alfirevic Z; Neilson JP
    BMJ; 2004 Oct; 329(7470):811-2. PubMed ID: 15472238
    [No Abstract]   [Full Text] [Related]  

  • 24. First trimester Down syndrome screening: distribution of markers and comparison of assays for quantification of pregnancy-associated plasma protein-A.
    Wøjdemann KR; Larsen SO; Rode L; Shalmi A; Sundberg K; Christiansen M; Tabor A
    Scand J Clin Lab Invest; 2006; 66(2):101-11. PubMed ID: 16537243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome.
    Spencer K
    Ann Clin Biochem; 2001 Jul; 38(Pt 4):413-4. PubMed ID: 11471889
    [No Abstract]   [Full Text] [Related]  

  • 26. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility of using plasma rather than serum in first and second trimester multiple marker Down's syndrome screening.
    Lambert-Messerlian GM; Palomaki GE; Eklund EE; Kloza EM; Neveux LM; Phipps MG; Canick JA
    J Med Screen; 2012 Dec; 19(4):164-70. PubMed ID: 23277614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy].
    Yu DY; Fu P; Zhang ZH; Wang F; Han MY; Ren HY; Zhao W; Zhang K; Li S; Jiang N
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):332-5. PubMed ID: 21644235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Maternal serum screening for Down's syndrome].
    Muller F
    Ann Biol Clin (Paris); 2002; 60(6):689-92. PubMed ID: 12446233
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of new biomarkers for Down's syndrome in maternal plasma.
    Heywood W; Mills K; Wang D; Hogg J; Madgett TE; Avent ND; Chitty LS
    J Proteomics; 2012 May; 75(9):2621-8. PubMed ID: 22456345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased time-to-pregnancy and first trimester Down's syndrome screening.
    Ranta JK; Raatikainen K; Romppanen J; Pulkki K; Heinonen S
    Hum Reprod; 2010 Feb; 25(2):412-7. PubMed ID: 19945962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated screening for Down's syndrome.
    Chen FM
    J Fam Pract; 1999 Nov; 48(11):846-7. PubMed ID: 10907617
    [No Abstract]   [Full Text] [Related]  

  • 34. Placental growth hormone in Down's syndrome screening.
    Baviera G; Carbone C; Corrado F; Mastrantonio P
    J Matern Fetal Neonatal Med; 2004 Oct; 16(4):241-3. PubMed ID: 15590454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ductus venosus pulsatility index as an antenatal screening marker for Down's syndrome: use with the Combined and Integrated tests.
    Borrell A; Borobio V; Bestwick JP; Wald NJ
    J Med Screen; 2009; 16(3):112-8. PubMed ID: 19805751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum müllerian-inhibiting substance in Down's syndrome pregnancies.
    Seifer DB; MacLaughlin DT; Cuckle HS
    Hum Reprod; 2007 Apr; 22(4):1017-20. PubMed ID: 17218369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester.
    Christiansen M; Nørgaard-Pedersen B
    Clin Genet; 2005 Jul; 68(1):35-9. PubMed ID: 15952984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome.
    Wald N; Stone R; Cuckle HS; Grudzinskas JG; Barkai G; Brambati B; Teisner B; Fuhrmann W
    BMJ; 1992 Jul; 305(6844):28. PubMed ID: 1379094
    [No Abstract]   [Full Text] [Related]  

  • 39. Antenatal screening policies for Down's syndrome. Audit of Down's syndrome screening is not valid.
    Wald NJ; Huttly W; Hackshaw AK
    BMJ; 2002 Nov; 325(7371):1034; author reply 1034. PubMed ID: 12411371
    [No Abstract]   [Full Text] [Related]  

  • 40. Performance of antenatal reflex DNA screening for Down's syndrome.
    Wald NJ; Bestwick JP
    J Med Screen; 2015 Dec; 22(4):168-74. PubMed ID: 25882667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.